Abstract
Fifty patients with either lymphoid or selected solid tumor malignancies were apheresed an identical number of times for PBSC collection after being randomized to receive either G-CSF 10 μ g/kg/day alone (arm I), or G-CSF at the same dose with GM-CSF 5 μ g/kg/day (arm II). Growth factor(s) was/were given as the stem cell mobilizing agent for 5 days before the start of PBSC collection, and were continued throughout the 4 days of apheresis. Aspiration and cryopreservation of autologous bone marrow occurred on day 3 or 4 of growth factor(s). Thirty-one of 50 patients received one cycle only at time of evaluation, and 19 patients received two cycles of HDCT, each supported with PBSC with or without autologous bone marrow. No patients received growth factors post-autologous stem cell transplant, unless the absolute neutrophils count (ANC) failed to recover to ⩾100/μ l by day +18 post-transplant. The median number of days to recovery of ANC to 100/μ l, 500/μ l and 1000/μ l, and of platelet counts to 20 000/μ l, 50 000/μ l and 100 000/μ l after either cycle 1 or cycle 2 of HDCT and the number of febrile days and platelet and PRBC transfusion requirements was not significantly different between the two arms of the study. The duration of hospitalization was similar between study arms for cycle 1 of HDCT, but was 3.5 days less with arm II compared to arm I (P = 0.0248) for cycle 2 of HDCT. The bone marrow buffy coat and PBSC product mononuclear cell count (× 108/kg) and CD34+ cell count (× 106/kg) collected by each method of stem cell mobilization was not significantly different. There is questionable clinical benefit with PBSC products mobilized with the combination of G-CSF and GM-CSF vs G-CSF alone. Perhaps different dosages, schedules, or other growth factor combinations with G-CSF might enhance these differences.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Spitzer, G., Adkins, D., Mathews, M. et al. Randomized comparison of G-CSF + GM-CSF vs G-CSF alone for mobilization of peripheral blood stem cells: effects on hematopoietic recovery after high-dose chemotherapy. Bone Marrow Transplant 20, 921–930 (1997). https://doi.org/10.1038/sj.bmt.1700999
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1700999
Keywords
This article is cited by
-
Novel agents and approaches for stem cell mobilization in normal donors and patients
Bone Marrow Transplantation (2012)
-
Proposed definition of ‘poor mobilizer’ in lymphoma and multiple myeloma: an analytic hierarchy process by ad hoc working group Gruppo ItalianoTrapianto di Midollo Osseo
Bone Marrow Transplantation (2012)
-
G-CSF and GM-CSF as therapeutic targets in rheumatoid arthritis
Nature Reviews Rheumatology (2009)
-
Improving stem cell mobilization strategies: future directions
Bone Marrow Transplantation (2009)
-
Mobilizing stem cells from normal donors: is it possible to improve upon G-CSF?
Bone Marrow Transplantation (2007)